![Leslie Holsinger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Leslie J.
Holsinger worked as a Group Leader at Sugen, Inc. and as the Head of Cell Biology Division at Celera Group.
Later, she worked as the Vice President of Biology at Virobay, Inc. from 2011 to 2016.
Currently, she is the Executive Vice President of Research and Development at Quince Therapeutics, Inc. since 2020.
Holsinger holds a doctorate from Northwestern University and an undergraduate degree from Occidental College.
Anciens postes connus de Leslie Holsinger
| Sociétés | Poste | Fin |
|---|---|---|
| QUINCE THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 31/07/2022 |
Virobay, Inc.
 Virobay, Inc. Pharmaceuticals: MajorHealth Technology Develops protease inhibitors for the treatment of neuropathic pain, cancer, autoimmune and liver diseases | Corporate Officer/Principal | 01/01/2016 |
Celera Group
 Celera Group Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics for cancer, autoimmune and inflammatory diseases | Corporate Officer/Principal | - |
Sugen, Inc.
 Sugen, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs and related pharmaceutical products | Corporate Officer/Principal | - |
Formation de Leslie Holsinger
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
18
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Sugen, Inc.
Sugen, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs and related pharmaceutical products | Health Technology |
Virobay, Inc.
Virobay, Inc. Pharmaceuticals: MajorHealth Technology Develops protease inhibitors for the treatment of neuropathic pain, cancer, autoimmune and liver diseases | Health Technology |
Celera Group
Celera Group Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics for cancer, autoimmune and inflammatory diseases | Health Technology |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Occidental College
 Occidental College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Quince Therapeutics, Inc.
 Quince Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of central nervous system disorders and Alzheimer’s diseases | Health Technology |
Choisissez Zonebourse 
